Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 12, Number 6—June 2006

Research

Multidrug-resistant Commensal Escherichia coli in Children, Peru and Bolivia

Alessandro Bartoloni*Comments to Author , Lucia Pallecchi†, Marta Benedetti*, Connie Fernandez‡, Yolanda Vallejos§, Elisa Guzman¶, Ana Liz Villagran§, Antonia Mantella*, Chiara Lucchetti†, Filippo Bartalesi*, Marianne Strohmeyer*, Angela Bechini*, Herlan Gamboa§, Hugo Rodríguez‡, Torkel Falkenberg#, Göran Kronvall#, Eduardo Gotuzzo**, Franco Paradisi*, and Gian Maria Rossolini†
Author affiliations: *Università di Firenze, Florence, Italy; †Università di Siena, Siena, Italy; ‡Hospital Apoyo Yurimaguas, Yurimaguas–Loreto, Peru; §Servicio Departamental de Salud Santa Cruz, Camiri, Bolivia; ¶Hospital Moyobamba, Moyobamba–San Martin, Peru; #Karolinska Institute, Stockholm, Sweden; **Universidad Peruana Cayetano Heredia, Lima, Peru

Main Article

Figure 2

Total prevalence, by age group, of fecal carriage of antimicrobial drug–resistant Escherichia coli among 3,174 children in 4 urban areas of Bolivia and Peru. Ceftriaxone and amikacin were not considered in these analyses because their resistance rates were too low.

Figure 2. Total prevalence, by age group, of fecal carriage of antimicrobial drug–resistant Escherichia coli among 3,174 children in 4 urban areas of Bolivia and Peru. Ceftriaxone and amikacin were not considered in these analyses because their resistance rates were too low.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO